Dr. Mehdi Khosravi, MD

Dr. Khosravi practices at University of Kentucky Albert B. Chandler Hospital in Lexington, Kentucky, part of University of Kentucky HealthCare.

Dr. Khosravi's NPI, 1942262506, was assigned on April 6, 2006. Dr. Khosravi graduated from Iran University of Medical Sciences in 1997. Dr. Khosravi holds Kentucky license 40372.

Dr. Khosravi's primary practice is University of Kentucky Albert B. Chandler Hospital, at 800 Rose Street, Lexington, KY 40536 in Fayette County. The practice phone is (859) 257-2278.

Dr. Khosravi's primary practice is University of Kentucky Albert B. Chandler Hospital in Lexington, Kentucky, part of University of Kentucky HealthCare. The medical group on file is University of Kentucky General Pediatrics. Dmand AI also links Dr. Khosravi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khosravi practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Khosravi's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Khosravi is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Khosravi's licenses on file in 4 states: Kentucky, Wisconsin, Illinois and Michigan.

CMS data shows 261 Medicare services from Dr. Khosravi across 9 procedure codes in 2024, for 152 Medicare patients. Medicare paid $18,423 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 152 Medicare patients who saw Dr. Khosravi in 2024. The largest group is 65 to 74, with 76 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khosravi's median patient age at 71, with 59% women.

In 2024, Dr. Khosravi wrote 1,202 Medicare Part D claims for 92 patients. 54% of them were for generic drugs. CMS names the drug for 1,037 of them, across 30 drugs with 11 or more claims each, at $926,312 in total drug cost. In 2023, CMS named 780 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Khosravi for performance year 2024, reported as part of a group. Dr. Khosravi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 22 papers to Dr. Khosravi, published from 2012 to 2024. 2012 was the busiest year, with 2. The most frequent topics are Lung, Vagus Nerve and Administration, Inhalation. Dr. Khosravi has published most often in Am J Physiol Regul Integr Comp Physiol. Dr. Khosravi's most frequent co-authors are Don Hayes, MD, Kristine M. Lohr, MD, MS and Ashish Prakash Maskey, MBBS.

Dmand AI links Dr. Khosravi to 1 clinical trial. Conditions studied include Pulmonary Atelectasis and Solitary Pulmonary Nodule.

CMS Open Payments shows 3 general payments to Dr. Khosravi from 3 drug and device companies from 2019 to 2024. Consulting fees make up the largest share, 95% of the total. Merck Sharp & Dohme Corporation paid the most, $1,395.

Dr. Khosravi graduated from Iran University of Medical Sciences in 1997. Dr. Khosravi is a member of ACCP, SCCM, ACP, AMA and ATS.

Dr. Khosravi is in network with 14 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.